Posted by whkwoon > 2013-11-26 09:55 | Report Abuse

Huge volume good sign

Posted by lee9fold > 2013-11-26 09:57 | Report Abuse

suddenly up?

Posted by Que Haifa > 2013-11-26 10:07 | Report Abuse

goreng time...3 white soldier?

Posted by Alex Leow Sze Shen > 2013-11-26 10:25 | Report Abuse

if u see the boilenger band, it's going to burst already! So report we shall put aside now!

Posted by Que Haifa > 2013-11-26 10:32 | Report Abuse

keep hold? alex

Posted by Alex Leow Sze Shen > 2013-11-26 10:43 | Report Abuse

i manage to sell all at 0.36 just now, take quick profit from 0.335 to 0.34 a few days back

Posted by Que Haifa > 2013-11-26 10:51 | Report Abuse

aiyo tadi kata keep bcos profit still intact...tpi sekarang u jual semua?

Posted by Matthew Law Thong Sheng > 2013-11-26 10:53 | Report Abuse

=.= slapping his own mouth

Posted by Que Haifa > 2013-11-26 10:55 | Report Abuse

ape la -_-

Posted by Alex Leow Sze Shen > 2013-11-26 11:04 | Report Abuse

take profit 1st, enter balik soon! :)

Posted by Alex Leow Sze Shen > 2013-11-26 11:04 | Report Abuse

As I said still going to uptrend :)

Posted by Alex Leow Sze Shen > 2013-11-26 11:10 | Report Abuse

Sapu balik at 0.35! Queue!

Posted by Alex Leow Sze Shen > 2013-11-26 11:10 | Report Abuse

Sapu balik WB at 0.175, queue!

Posted by lee9fold > 2013-11-26 11:16 | Report Abuse

woah alex...why in and out? so fun kah

Posted by Alex Leow Sze Shen > 2013-11-26 11:18 | Report Abuse

Play Hovid is like that lah, coz quite slow, so must catch the fish and then release then catch back

Posted by singinvestor > 2013-11-26 12:27 | Report Abuse

Your broker will like player that catch and release........

Posted by Alex Leow Sze Shen > 2013-11-26 12:30 | Report Abuse

singinvestor, yes, that's why lor! :) Broker untung, then tips also banyak lah! Give n take :P

Posted by lee9fold > 2013-11-26 13:52 | Report Abuse

wad else insider news alex

Posted by Alex Leow Sze Shen > 2013-11-26 14:49 | Report Abuse

No insider news for the time being, play based on chart only!

Posted by singinvestor > 2013-11-26 15:28 | Report Abuse

Alex, what is your TP before release the fish again? :0

Posted by Alex Leow Sze Shen > 2013-11-26 18:24 | Report Abuse

TP is 0.37!

Posted by Matthew Law Thong Sheng > 2013-11-26 18:29 | Report Abuse

that means ur goreng season finish le?

Posted by Alex Leow Sze Shen > 2013-11-26 20:21 | Report Abuse

Wait...chart session tells me that Hovid will have another wave of uptrend, my TP is 0.37 only for this 2 days! 0.39 is the TP! If it surpass this price, 0.41 on the way!

Posted by lee9fold > 2013-11-26 23:15 | Report Abuse

u do own TA analysis?

Posted by leslieroycarter > 2013-11-27 15:39 | Report Abuse

doji appears , may be trend reversal ?

Posted by cmlooi > 2013-11-28 01:54 | Report Abuse

No doji lah bro. You must see the location of the cross forms. You should get concerned when it is formed after a number of days of movement. RSI rebounded and is rising and OBV also rising. GMMA looks good.

Posted by Alex Leow Sze Shen > 2013-11-28 14:26 | Report Abuse

lee9fold: Yes, I do my own analysis

Posted by Wei Xin > 2013-11-28 14:56 | Report Abuse

0.335 better to accumulate....waiting...see match or not...

Posted by necro > 2013-11-29 20:25 | Report Abuse

Throw no or no more later

Posted by Alex Leow Sze Shen > 2013-12-01 15:21 | Report Abuse

Buy now or no more later!

Posted by KY Lau > 2013-12-02 20:51 | Report Abuse

30sen or below buy

Posted by Alex Leow Sze Shen > 2013-12-02 21:42 | Report Abuse

Lowest hit is 0.33 only then it will rebound :)

Posted by Alex Leow Sze Shen > 2013-12-02 21:46 | Report Abuse

http://www.theedgemalaysia.com/business-news/265595-klci-week-ahead-klci-likely-to-kick-off-4q-on-firmer-footing-.html ---> Hovid recomended Buy!

Posted by Alex Leow Sze Shen > 2013-12-04 11:50 | Report Abuse

Published: Wednesday December 4, 2013 MYT 8:23:00 AM
Updated: Wednesday December 4, 2013 MYT 8:25:48 AM

CIMB Research begins coverage of Hovid, target price 43 sen


KUALA LUMPUR: CIMB Equities Research has started coverage of Hovid with an Outperform call and a target price of 43 sen, based on sum-of-parts valuation.

It said on Wednesday the re-rating catalysts could come from increased product registrations in its export markets and strong earnings growth.

Hovid started as a herbal tea maker in 1941 and began producing generic drugs in the 1980s. It prides itself on having the largest export sales among Malaysia-listed pharma companies, deriving half of its revenue (53% in FY13) from exports.

It also has a strong R&D culture, judging from its long list of accolades in manufacturing innovations. These positives are no longer eclipsed by its loss-making subsidiary, Carotech, which it disposed of in 2011.

“Hovid's key markets offer solid growth opportunities. Healthcare spending in Malaysia and some of its key export markets, such as Nigeria, Cambodia and Myanmar, is low by international standards.

“Rising affluence and improved access to healthcare services will fuel demand for drugs. Increased product registrations will also boost Hovid's future earnings by opening up new markets for the group as more drugs will be allowed for sale in countries where the drugs were previously unapproved,” said the research house.

CIMB Research added that Hovid is seeking approval from the US FDA to sell Tocovid SupraBio (a type of Vitamin E) as a drug that could reduce brain damage caused by strokes. If successful, it could open up a blue ocean that is worth billions of dollars in annual sales.

It described Hovid as a defensive growth stock. Hovid's earnings are defensive, as attested by its consistent EBITDA (ex-Carotech) growth during the global financial crisis in 2007-2009.
“Our valuation of 43 sen per share does not include the value of Tocovid SupraBio as a potential drug as its approval could take at least another three to five years. Even without it, we believe that Hovid looks attractive given its strong growth potential,” it said.

Posted by lee9fold > 2013-12-04 12:07 | Report Abuse

hahaha alex

Posted by whizzkid125 > 2013-12-04 13:10 | Report Abuse

bought a quite a number today , hope for the coming upsurge...TP of 43 cents is good enough, may even go higher depending on the market.

Posted by Wolverine > 2013-12-04 13:55 | Report Abuse

@whizzkid125
At price did you buy ?

Posted by whizzkid125 > 2013-12-04 14:15 | Report Abuse

at 34 cents & hope to collect more later on...please read this..

Hovid Bhd - Our drug of choice
We like Hovid, Malaysia’s largest pharmaceutical exporter, for its earnings
growth potential, resilient earnings and efforts to register Tocovid SupraBio as a drug. If successful, Tocovid could generate billions of dollars in annual sales.
We begin coverage on the stock with an Outperform call and a target price of
RM0.43, based on SOP valuation. Re-rating catalysts could come from
increased product registrations in its export markets and strong earnings
growth.

Posted by Alex Leow Sze Shen > 2013-12-04 15:25 | Report Abuse

Good choice, now CIMB already coverage buy! Outperform summore, must buy!

Posted by Xplosiv3 > 2013-12-04 15:39 | Report Abuse

how about hovid-wb...lolzz

Posted by whizzkid125 > 2013-12-04 16:03 | Report Abuse

Xplosiv3 how about hovid-wb...lolzz
04/12/2013 15:39


buy too, it will go higher than mother perhaps

Posted by Alex Leow Sze Shen > 2013-12-04 16:41 | Report Abuse

It's gaining power now! Now price not moving, good time to buy, CNY rally!

Posted by whizzkid125 > 2013-12-04 16:55 | Report Abuse

not bad closing today for both mother & son....tomorrow goreng higher.

Posted by Alex Leow Sze Shen > 2013-12-04 16:58 | Report Abuse

yes, remember to see the boilinger band! It's opening up soon!

Posted by Alex Leow Sze Shen > 2013-12-05 00:35 | Report Abuse

Higher return from warrants Investors with a bigger risk appetite may prefer Hovid's warrants, which are currently
trading at RM0.17. With more than four years to maturity and an exercise price of RM0.18, the warrants would be worth at least RM0.25 should
Hovid's share price rise to RM0.43. This represents upside potential of 52% for Hovid's warrants.

Posted by Alex Leow Sze Shen > 2013-12-05 00:35 | Report Abuse

Tocovid SupraBio is currently sold as a dietary supplement. Unlike drugs, dietary supplements cannot make the claim of being able to prevent, treat orcure illnesses due to regulatory restrictions. Hovid is seeking approval from the US FDA to sell Tocovid as a drug that could aid stroke patients. A mid-stageclinical trial on Tocovid will be carried out soon and the company is hopeful ofobtaining approval in the next 3-5 years. Earlier tests have produced strong statistical evidence of the effectiveness of Tocovid in decreasing brain damagecaused by strokes. We gathered that the estimated cost of the clinical trial is around US$3m. Hovid could be sitting on a gold mine if it manages to get FDA approval eventually as there is currently no specific treatment to reduce brain damage in stroke patients. The potential market size for Tocovid is vast.

Posted by whizzkid125 > 2013-12-05 03:04 | Report Abuse

Thank you brother Alex Leow Sze Shen for the updates. I see that Hovid will move more from today onwards with the new research report just out. Will be collecting more today & more if it progresses further. As brother Alex just said, we are sitting on a gold mine & I see great potential coming in possible billions of dollars sales.

Posted by whizzkid125 > 2013-12-05 08:13 | Report Abuse

today it will go higher, go for it early.

Posted by kerengga > 2013-12-05 09:18 | Report Abuse

Tocovid SupraBio already registered as a Patent in Europe!!

https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/c9ba54e8b14044f03d1f/EP2044936B1.pdf

Posted by kerengga > 2013-12-05 09:20 | Report Abuse

its a great product from our palm oil industries...cheers everybody...this is multi billion bussines...